A detailed history of Newbridge Financial Services Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 800 shares of AZN stock, worth $57,136. This represents 0.02% of its overall portfolio holdings.

Number of Shares
800
Previous 800 -0.0%
Holding current value
$57,136
Previous $54,000 14.81%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$61.03 - $69.57 $48,824 - $55,655
800 New
800 $54,000
Q3 2023

Oct 17, 2023

BUY
$64.85 - $71.7 $64 - $71
1 Added 0.07%
1,456 $98,000
Q2 2023

Jul 21, 2023

SELL
$69.91 - $75.81 $16,009 - $17,360
-229 Reduced 13.6%
1,455 $104,000
Q1 2023

Apr 18, 2023

SELL
$63.15 - $71.6 $6,820 - $7,732
-108 Reduced 6.03%
1,684 $116,000
Q4 2022

Jan 17, 2023

SELL
$54.21 - $70.44 $8,510 - $11,059
-157 Reduced 8.06%
1,792 $0
Q3 2022

Oct 13, 2022

BUY
$53.02 - $135.75 $159 - $407
3 Added 0.15%
1,949 $107,000
Q2 2022

Jul 15, 2022

SELL
$59.26 - $71.14 $2,725 - $3,272
-46 Reduced 2.31%
1,946 $129,000
Q1 2022

Apr 26, 2022

BUY
$55.72 - $67.12 $334 - $402
6 Added 0.3%
1,992 $132,000
Q4 2021

Jan 19, 2022

BUY
$54.02 - $63.83 $50,994 - $60,255
944 Added 90.6%
1,986 $116,000
Q3 2021

Oct 27, 2021

BUY
$55.56 - $60.79 $1,722 - $1,884
31 Added 3.07%
1,042 $63,000
Q1 2021

Sep 07, 2021

BUY
$47.16 - $54.44 $9,950 - $11,486
211 Added 26.38%
1,011 $50,000
Q4 2020

Sep 07, 2021

SELL
$48.52 - $58.02 $5,240 - $6,266
-108 Reduced 11.89%
800 $40,000
Q3 2020

Sep 07, 2021

BUY
$53.07 - $61.1 $48,187 - $55,478
908 New
908 $50,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $221B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.